Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 2

Results: 15
    1

    Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 311, doi. 10.1007/s00262-017-2073-0
    By:
    • Moore, Tamson;
    • Wagner, Courtney Regan;
    • Scurti, Gina M.;
    • Hutchens, Kelli A.;
    • Godellas, Constantine;
    • Clark, Ann Lau;
    • Kolawole, Elizabeth Motunrayo;
    • Hellman, Lance M.;
    • Singh, Nishant K.;
    • Huyke, Fernando A.;
    • Wang, Siao-Yi;
    • Calabrese, Kelly M.;
    • Embree, Heather D.;
    • Orentas, Rimas;
    • Shirai, Keisuke;
    • Dellacecca, Emilia;
    • Garrett-Mayer, Elizabeth;
    • Li, Mingli;
    • Eby, Jonathan M.;
    • Stiff, Patrick J.
    Publication type:
    Article
    2

    Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.

    Published in:
    2018
    By:
    • Moore, Tamson;
    • Wagner, Courtney Regan;
    • Scurti, Gina M.;
    • Hutchens, Kelli A.;
    • Godellas, Constantine;
    • Clark, Ann Lau;
    • Kolawole, Elizabeth Motunrayo;
    • Hellman, Lance M.;
    • Singh, Nishant K.;
    • Huyke, Fernando A.;
    • Wang, Siao-Yi;
    • Calabrese, Kelly M.;
    • Embree, Heather D.;
    • Orentas, Rimas;
    • Shirai, Keisuke;
    • Dellacecca, Emilia;
    • Garrett-Mayer, Elizabeth;
    • Li, Mingli;
    • Eby, Jonathan M.;
    • Stiff, Patrick J.
    Publication type:
    Correction Notice
    3

    Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 329, doi. 10.1007/s00262-017-2101-0
    By:
    • Yuan, Xiaopeng;
    • Yang, Mingjuan;
    • Chen, Xiang;
    • Zhang, Xuhua;
    • Sukhadia, Shrey;
    • Musolino, Najia;
    • Bao, Huijing;
    • Chen, Tingtao;
    • Xu, Chen;
    • Wang, Qirui;
    • Santoro, Stephen;
    • Ricklin, Daniel;
    • Hu, Jia;
    • Lin, Ruihe;
    • Yang, Wei;
    • Li, Zhijun;
    • Qin, Weijun;
    • Zhao, Aizhi;
    • Scholler, Nathalie;
    • Coukos, George
    Publication type:
    Article
    4
    5

    A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 247, doi. 10.1007/s00262-017-2081-0
    By:
    • Fisher, Timothy S.;
    • Hooper, Andrea T.;
    • Lucas, Justin;
    • Clark, Tracey H.;
    • Rohner, Allison K.;
    • Peano, Bryan;
    • Elliott, Mark W.;
    • Tsaparikos, Konstantinos;
    • Wang, Hui;
    • Golas, Jonathan;
    • Gavriil, Maria;
    • Haddish-Berhane, Nahor;
    • Tchistiakova, Lioudmila;
    • Gerber, Hans-Peter;
    • Root, Adam R.;
    • May, Chad
    Publication type:
    Article
    6
    7

    A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 285, doi. 10.1007/s00262-017-2085-9
    By:
    • Gasser, Olivier;
    • Sharples, Katrina J.;
    • Barrow, Catherine;
    • Williams, Geoffrey M.;
    • Bauer, Evelyn;
    • Wood, Catherine E.;
    • Mester, Brigitta;
    • Dzhelali, Marina;
    • Caygill, Graham;
    • Jones, Jeremy;
    • Hayman, Colin M.;
    • Hinder, Victoria A.;
    • Macapagal, Jerome;
    • McCusker, Monica;
    • Weinkove, Robert;
    • Painter, Gavin F.;
    • Brimble, Margaret A.;
    • Findlay, Michael P.;
    • Dunbar, P. Rod;
    • Hermans, Ian F.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15